跳至主要内容
临床试验/PER-063-09
PER-063-09已完成未知

EFFECTIVENESS AND SAFETY OF ETORICOXIB IN THE TREATMENT OF EXTRA-ARTICULAR REUMATISMS OF THE SHOULDER.

MERCK SHARP & DOHME PERU S.R.L.,0 个研究点目标入组 45 人开始时间: 2009年7月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 80(—)
性别
All

入选标准

  • Outpatients, both sexes and over 18 years.
  • 2 Diagnosis of extra-articular rheumatism affecting the shoulder (supraspinatus tendonitis, bicipital tendonitis, Infraspinatus tendonitis, subacromial bursitis, etc.)
  • Pain in the shoulder, of non-traumatic origin.
  • History of unrestricted and non-painful movement of! shoulder before the beginning of the episode of acute pain.
  • Acute unilateral shoulder pain, caused by extra-articular rheumatism.
  • Active movement pain greater than 50 mm on a visual scale analogous to 100 mm pain.
  • The use of non-steroidal anti-inflammatory drugs is required to relieve symptoms.

排除标准

  • Active or recurrent ulcer-peptic disease (gastric or duodenal).
  • 2 History of peptic ulcer or gastrointestinal bleeding.
  • Coagulation disorders or history of cerebral bleeding or bleeding other than gastrointestinal.
  • For women of gestational age, pregnancy or at risk of being pregnant.
  • Women breastfeeding.
  • Concomitant treatment with anti-coagulants, including warfarin, heparin or other anticoagulants.
  • Concomitant treatment with lithium.
  • Concomitant treatment with other NSAIDs (the previous 3 days), or aspirin at doses equal to or greater than 75 mg per day.
  • Concomitant treatment with paracetamol (at doses greater than 2 g / day).
  • Patients under treatment with corticosteroids currently or during the previous three months (oral, intramuscular or intravenous).
  • Use of any intralesional therapy (corticosteroids, hyaluronates, etc.) in the affected shoulder during the 6 months prior to admission to the study.
  • Hospitalization planned for any cause or surgery planned during the clinical study.
  • History of previous surgery or surgical intervention for any cause in the affected shoulder.
  • Surgical indication or planned surgery on the affected shoulder.
  • Suspicion of glenohumeral arthritis in the affected shoulder.
  • Suspicion of septic arthritis in the affected shoulder.
  • Suspicion of any form of crystal arthropathy (gout, pseudogout, dihydrated calcium pyrophosphate crystal disease), or chondrocalcinosis, charcot arthropathy, osteonecrosis, terminal rheumatic disease or infectious or non-infectious arthritis in the affected shoulder.
  • Presence of adhesive capsules on the affected shoulder.
  • Suspicion of pain in irradiated or referred shoulder
  • History of major traumatic events in the shoulder that have produced disability.
  • History of previous myocardial infarction or angina pectoris
  • History of coronary bypass or previous cardiac surgery
  • History of uncontrolled arterial hypertension

研究者

发起方
MERCK SHARP & DOHME PERU S.R.L.,

相似试验

进行中(未招募)
不适用
Die perioperative Anwendung von Etoricoxib verglichen mit Diclofenac bei Patienten nach Implantation einer Hüftgelenkstotalendoprothese, prospektive, doppelt blinde Phase IIIb Studie - ARCOXIAIn this clinical trial we will investigate patients who suffer from primary or secondary coxarthrosis where an implantation of a total hip joint endoprosthesis is indicated. It will be analyzed whether the use of Etoricoxib as compared to Diclofenac leads to a reduction of the perioperative risk of bleedings.MedDRA version: 12.1Level: LLTClassification code 10048793Term: Coxarthrosis
EUCTR2009-015383-33-DEFreistaat Bayern, vertreten durch die Universität Regensburg
进行中(未招募)
不适用
Etoricoxib als präemptives Analgetikum bei therapeutischen Arthroskopie
EUCTR2006-000451-17-DEMarienkrankenhaus Soest66
进行中(未招募)
不适用
Wirksamkeit von Etoricoxib bei Patienten mit neuropathischen Schmerzen mit und ohne peripherer Hyperalgesie(Efficacy of etoricoxibe in patients with neuropathic pain with and without peripheral hyperalgesia)
EUCTR2009-015496-27-DEBG university hospital Bergmannsheil GmbH65
已完成
3 期
evaluation of two doses of Etoricoxib (90mg and 120mg) as pre-operative preemptive analgesic for postoperative pain relief in mandibular fracture surgery
CTRI/2017/08/009272All India Institute Of Medical Sciences New Delhi60
招募中
4 期
The effectiveness of etoricoxib compare with acetaminophen as analgesia for post-operative pain relief in lumbar laminectomypost&#45operative pain after lumbar laminactomylaminectomyoperative painmorphineEtoricoxib
TCTR20181223001Invitation research grant, Faculty of Medicine KK40